Basic Information
RNALocate ID: | RLID:11002555 |
RNA Symbol: | hsa-miR-382-5p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-382 |
RNA ID: | miRBase:MIMAT0000737 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002047 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:11002548 | Exosome | Serum | 18589210 |
RLID:11002549 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11002550 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID:11002551 | Exosome | Brain tissue | 23382797 |
RLID:11002552 | Exosome | Plasma | 23663360 |
RLID:11002553 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11002554 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID-D:11000126 | Exosome | Blood | |
RLID-D:11000425 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-382-5p | Pheochromocytoma | MNDR-E-MI-47191 |
MNDR | hsa-miR-382-5p | Oral squamous cell carcinoma | MNDR-E-MI-47192 |
MNDR | hsa-miR-382-5p | Medulloblastoma | MNDR-E-MI-47193 |
MNDR | hsa-miR-382-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-47194 |
MNDR | hsa-miR-382-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-47195 |
MNDR | hsa-miR-382-5p | Lymphoma | MNDR-E-MI-47196 |
MNDR | hsa-miR-382-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-47197 |
MNDR | hsa-miR-382-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-47198 |
MNDR | hsa-miR-382-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-47199 |
MNDR | hsa-miR-382-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-47200 |
MNDR | hsa-miR-382-5p | Her2-receptor positive breast cancer | MNDR-E-MI-47201 |
MNDR | hsa-miR-382-5p | Niemann-pick disease type c | MNDR-E-MI-47202 |
MNDR | hsa-miR-382-5p | Dermatomyositis | MNDR-E-MI-47203 |
MNDR | hsa-miR-382-5p | Gastric cancer | MNDR-E-MI-47204 |
MNDR | hsa-miR-382-5p | Alzheimer disease | MNDR-E-MI-47205 |
MNDR | hsa-miR-382-5p | Dysautonomia familial | MNDR-E-MI-47206 |
MNDR | hsa-miR-382-5p | Muscular dystrophy duchenne | MNDR-E-MI-47207 |
MNDR | hsa-miR-382-5p | Head and neck cancer | MNDR-E-MI-47208 |
MNDR | hsa-miR-382-5p | Huntington disease | MNDR-E-MI-47209 |
MNDR | hsa-miR-382-5p | Chorea | MNDR-E-MI-47210 |
MNDR | hsa-miR-382-5p | Lung cancer | MNDR-E-MI-47211 |
MNDR | hsa-miR-382-5p | Fragile x syndrome | MNDR-E-MI-47212 |
MNDR | hsa-miR-382-5p | Parkinson disease | MNDR-E-MI-47213 |
MNDR | hsa-miR-382-5p | Niemann-pick disease | MNDR-E-MI-47214 |
MNDR | hsa-miR-382-5p | Breast cancer | MNDR-E-MI-47215 |
MNDR | hsa-miR-382-5p | Squamous cell carcinoma | MNDR-E-MI-47216 |
MNDR | hsa-miR-382-5p | Thyroid cancer | MNDR-E-MI-47217 |
MNDR | hsa-miR-382-5p | Pituitary neoplasms | MNDR-E-MI-47218 |
MNDR | hsa-miR-382-5p | Pancreatic cancer | MNDR-E-MI-47219 |
MNDR | hsa-miR-382-5p | Melanoma | MNDR-E-MI-47220 |
MNDR | hsa-miR-382-5p | Nephroblastoma | MNDR-E-MI-47221 |
MNDR | hsa-miR-382-5p | Ischemic attack transient | MNDR-E-MI-47222 |
MNDR | hsa-miR-382-5p | Colon adenocarcinoma | MNDR-E-MI-47223 |
MNDR | hsa-miR-382-5p | Familial ovarian cancer | MNDR-E-MI-47224 |
MNDR | hsa-miR-382-5p | Carcinoma ductal breast | MNDR-E-MI-47225 |
MNDR | hsa-miR-382-5p | Glioblastoma | MNDR-E-MI-47226 |
MNDR | hsa-miR-382-5p | Glioma | MNDR-E-MI-47227 |
MNDR | hsa-miR-382-5p | Nemaline myopathy | MNDR-E-MI-47228 |
MNDR | hsa-miR-382-5p | Chordoma | MNDR-E-MI-47229 |
MNDR | hsa-miR-382-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-47230 |
MNDR | hsa-miR-382-5p | Osteosarcoma | MNDR-E-MI-47231 |
MNDR | hsa-miR-382-5p | Meningioma | MNDR-E-MI-47232 |
MNDR | hsa-miR-382-5p | Uterine cancer | MNDR-E-MI-47233 |
MNDR | hsa-miR-382-5p | Gastric adenocarcinoma | MNDR-E-MI-47234 |
MNDR | hsa-miR-382-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-47235 |
MNDR | hsa-miR-382-5p | Lung squamous cell carcinoma | MNDR-E-MI-47236 |
MNDR | hsa-miR-382-5p | Lung adenocarcinoma | MNDR-E-MI-47237 |
MNDR | hsa-miR-382-5p | Adrenocortical carcinoma | MNDR-E-MI-47238 |
MNDR | hsa-miR-382-5p | Thyroid carcinoma | MNDR-E-MI-47239 |
MNDR | hsa-miR-382-5p | Ovarian carcinoma | MNDR-E-MI-47240 |
MNDR | hsa-miR-382-5p | Bladder urothelial carcinoma | MNDR-E-MI-47241 |
MNDR | hsa-miR-382-5p | Pancreatic adenocarcinoma | MNDR-E-MI-47242 |
MNDR | hsa-miR-382-5p | Carcinoma renal cell | MNDR-E-MI-47243 |
MNDR | hsa-miR-382-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-47244 |
MNDR | hsa-miR-382-5p | Clear cell renal cell carcinoma | MNDR-E-MI-47245 |
MNDR | hsa-miR-382-5p | Adenocarcinoma of esophagus | MNDR-E-MI-47246 |
MNDR | hsa-miR-382-5p | Esophageal cancer | MNDR-E-MI-47247 |
MNDR | hsa-miR-382-5p | Prolactinoma | MNDR-E-MI-47248 |
MNDR | hsa-miR-382-5p | Synovial sarcoma | MNDR-E-MI-47249 |
MNDR | hsa-miR-382-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-47250 |
MNDR | hsa-miR-382-5p | Breast invasive carcinoma | MNDR-E-MI-47251 |
MNDR | hsa-miR-382-5p | Familiar ovarian carcinoma | MNDR-E-MI-47252 |
MNDR | hsa-miR-382-5p | Retinoblastoma | MNDR-E-MI-47253 |
MNDR | hsa-miR-382-5p | Skin cutaneous melanoma | MNDR-E-MI-47254 |
MNDR | hsa-miR-382-5p | Skin melanoma | MNDR-E-MI-47255 |
MNDR | hsa-miR-382-5p | Colorectal cancer | MNDR-E-MI-47256 |
MNDR | hsa-miR-382-5p | Nasopharynx carcinoma | MNDR-E-MI-47257 |
MNDR | hsa-miR-382-5p | Nasopharyngeal cancer | MNDR-E-MI-47258 |
MNDR | hsa-miR-382-5p | Polymyositis | MNDR-E-MI-47259 |
MNDR | hsa-miR-382-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-47260 |
MNDR | hsa-miR-382-5p | Stroke lacunar | MNDR-E-MI-47261 |
MNDR | hsa-miR-382-5p | Breast cancer her3+ negative | MNDR-E-MI-47262 |
MNDR | hsa-miR-382-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-47263 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ATXN1 | Homo sapiens | RR00165932 |
TOP